Global X S&P Biotech ETF is a sector & thematic ETF from Global X — 157 holdings, with $39.6m under management. 76% of its money is in health care. Its two largest holdings, MODERNA INC and TWIST BIOSCIENCE, make up 4% of the fund. It charges 0.45% a year.
Compare CURE with another fund →UTHR
UNITED THERAPEUTICS
Health Care · United States · 1.26% of CURE on average
Contributed +$9 per $10k to CURE over the last month.
Loading…
Explained moves, and what each did to CURE
About CURE
- TypeSector & thematic
- IssuerGlobal X
- Size$39.6m
- Cost0.45% a year
- Holdings157
- Top sectorHealth Care 76%
- Top 2 holdings4%
CURE fell 2.1% over the last month. On $10,000, that's −$210. QURE was the biggest drag at −$43; MRNA helped most at +$100.
What moved it
Gain or loss per $10k invested
- MRNAModerna+$100
- GRALGrail+$65
- IOVAIovance+$63
- QUREUniqure−$43
- TWSTTwist+$38
- TVTXTravere−$33
- ARWRArrowhead−$33
- PRAXPraxis−$30
- INSMInsmed−$29
- NTRANatera+$28
- DNTHDianthus−$27
- SRRKScholar Rock−$27
- IBRXImmunitybio+$26
- BMRNBiomarin−$23
- ROIVRoivant−$23
- ORKAOruka−$23
- MIRMMirum−$21
- CELCCelcuity−$20
- CYTKCytokinetics−$19
- IONSIonis Pharma−$18
- SLSSellas Life−$18
- NKTRNektar−$18
- ALKSAlkermes−$17
- IMVTImmunovant−$16
- RXRXRecursion+$16
- SYRESpyre−$16
- INCYIncyte−$12
- RVMDRevolution−$10
- REGNRegeneron−$10
- CRSPCrispr−$9
- UTHRUnited Thera.+$9
- ABBVAbbVie+$9
- AMGNAmgen+$8
- TGTXTG Thera.−$6
- KRYSKrystal−$6
- PTGXProtagonist−$5
- EXELExelixis+$4
- HALOHalozyme+$4
- VRTXVertex Pharma−$3
- GILDGilead+$2
- BIIBBiogen+$1
- CurrencyForeign currencies against the Australian dollar+$204
- UnattributedHedging, fees, timing−$98
- CompoundingDaily returns multiply, they do not add−$28
- Fund return−$210
- Other 7 kinds of news−$4
- Other 5 kinds of news+$3
Each kind of news counts the days those moves happened; No flagged news is every other day. News is tracked for moves large enough to be flagged; most international holdings had none in this range.